Clinical Trial Update: Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES [NA]

View source ↗

Summary

A clinical trial comparing a bioabsorbable vascular scaffold (BVS) with the Xience drug-eluting stent in patients with coronary artery disease and diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• Absorb BVS (bioabsorbable vascular scaffold)
• Xience DES (everolimus-eluting stent)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Disease, Diabetes Mellitus | NA | Status: WITHDRAWN